Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

PHASE3CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

April 30, 2004

Study Completion Date

February 10, 2009

Conditions
Cancer
Interventions
DRUG

dexamethasone

DRUG

ondansetron

PROCEDURE

quality-of-life assessment

Trial Locations (14)

T6G 1Z2

Cross Cancer Institute, Edmonton

V1Y 5L3

British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna

V3V 1Z2

Fraser Valley Cancer Centre at British Columbia Cancer Agency, Surrey

V5Z 4E6

British Columbia Cancer Agency, Vancouver

B3H 1V7

Nova Scotia Cancer Centre, Halifax

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

P7B 6V4

Northwestern Ontario Regional Cancer Care, Thunder Bay

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

J1H 5N4

CHUS-Hopital Fleurimont, Fleurimont

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

H2W 1S6

McGill University, Montreal

H4L 2M1

Centre Hospitalier de l'Universite de Montreal, Montreal

G1R 2J6

Centre Hospitalier Universitaire de Quebec, Québec

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK